Caplacizumab [915810-67-2]

TargetMol Chemicals

Caplacizumab

9

915810-67-2

Chemical

Research Use Only

Caplacizumab (ALX-0681), a humanized anti-von Willebrand factor (vWF) nanobody, serves to impede vWF-mediated platelet adhesion, thereby averting additional microthrombi formation. This compound is utilized in the study of thrombotic thrombocytopenic purpura (TTP) [1].

3 years

-20°C

12352203